Home > Publications > Medical Specialty > Neurology > Multiple Sclerosis > Multiple Sclerosis Research Review Issue 90
Multiple Sclerosis Research Review Issue 90

Multiple Sclerosis Research Review Issue 90

In this issue:

2024 revised McDonald criteria
Corticosteroid treatment during relapse & long-term disability in MS
Care gaps in advanced MS
Smouldering activity with teriflunomide vs. ocrelizumab in RRMS
Extracellular vesicle-derived microRNAs as biomarkers for treatment response in MS
Elevated healthcare use up to 14–15 years before symptom onset in MS
Outcomes following a switch from fingolimod to B-cell-depleting therapy
Predictors of early CDA in newly diagnosed relapsing MS
McDonald criteria diagnostic performance: 2024 vs. 2017 vs. 2010
RADIUS-R & RADIUS-P: elezanumab in relapsing/progressive MS

You need to be logged in to access this content.

Todd Hardy Photo 20231207

Expert contributor

Clinical Professor Todd Hardy

Clinical Professor Todd Hardy is Staff Specialist Neurologist at Concord Hospital, Clinical Senior Lecturer in Medicine at the University of Sydney and Co-Director of the MS Clinic at the Brain & Mind Centre. Dr Hardy’s clinical and research interests are in the field of neuroimmunology. His main focus is on multiple sclerosis, including atypical forms […]

Latest Publications and Videos

Stay up to date with our latest clinical information.

Explore Research Review Publications and Videos

Dive into our publications and videos content from over 50 areas of medicine including Cardiology, Diabetes, Oncology, Haematology and Psychiatry. 

Find Reviews in Your Clinical Area
Please select your country of practice.

It looks like you are closest to our New Zealand site.

Terms and Conditions

Website terms of use 

By using our website, you agree to follow these terms and conditions. 

 

Privacy policy 

We take your privacy seriously. To understand how we collect, use, and protect your information, please read our Privacy Policy, which is part of these terms. 

 

Copyright and use of website content 

The content of our website is protected by copyright, trademarks, and other legal rights. You can: view, download, or print a single copy of content for your personal or professional use. 

You cannot:  copy, modify, or distribute website content, or use our website content for commercial purposes or in other works without permission. 

 

Links to third-party websites 

The Research Review website may link to third-party websites for your convenience. However: 

We do not endorse or approve their products, services, or actions. 

We are not responsible for their content or how they operate. 

There is no formal partnership between us and third parties unless we clearly state otherwise. 

 

Disclaimer and limitation of liability 

We do our best to keep the information on our website accurate, but we do not guarantee that it is always correct or up to date. 

To the fullest extent allowed by law, we are not responsible for: 

Any loss, damage, or costs you may suffer from using (or being unable to use) our website. 

Any decisions you make based on the information provided. 

Any business losses, such as lost profits, lost data, or business interruptions. 

 

Governing law 

These terms are governed by New Zealand law. If there is a dispute, it must be resolved in a New Zealand court.